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1. INTRODUCTION 
Bacterial adherence and the growth of bacteria on solid surfaces as biofilm are 
both naturally occurring phenomena. Bacteria form biofilm in a wide variety of 
environments and play a crucial role in many disciplines including medicine, dentistry, 
immunology, biotechnology and process engineering. In medicine biofilm infections have 
a major impact on temporary and permanent implants or devices placed in the human 
body. The most frequently used foreign bodies in urology are urethral catheters, ureteric 
and prostatic stents, penile, testicular implants and artificial urinary sphincters. Very often 
they have potentially serious consequences. Biofilms can have a positive impact as well, 
namely lining healthy intestine and female genito-urinary tract. Biofilms have significant 
implications for clinical pharmacology, particularly related to antibiotic resistance, drug 
adsorption onto and off of devices, and minimum inhibitory concentrations of drugs 
required for effective therapy. 
The fact that bacteria grow mostly on surfaces has been known for more than 150 
years. During this time microbiologists have used direct methods to examine natural 
populations of these organisms growing in real ecosystems. In 1547 Antonie van 
Leuwenhock used his primitive but effective microscope to describe aggregates of 
'animalcules' that he had scraped from human tooth surfaces. Almost 100 years later, in 
1934 Claude Zobell examined natural marine populations by direct microscopy and 
concluded that these bacteria are attracted to the surfaces to which they sometimes adhere, 
to form sessile populations. Steadily, throughout the history of microbiology, very few 
microbiologists have chosen to examine their subjects directly by microscopy and have 
found that bacteria grow differently after they adhere to a surface and initiate biofilm 
formation. In 1964 Ralph Mitchell and Kevin Marshall examined the first stages of 
biofilm formation by bacteria in pure cultures, and distinguished between the reversible 
adsorption of bacteria to surfaces and the subsequent irreversible attachment that 
constitutes the first stage of biofilm formation. Since then, extensive studies have been 
carried out to identify and understand the bacterial microenvironment-termed biofilm. [1] 
The definition of biofilm initially consisted of microorganisms and extracellular 
substances in association with substratum. Today, the definition not only includes 
aggregations of microorganisms and their extracellular products on surface but also those 
at some distance away and in dense and single layers. 
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1.1 Mechanism of biofilm formation 
The formation of biofilm generally consists of four steps (Figure 1) [2-8]: 
1. deposition of the microorganisms 
2. attachment of microorganisms followed by microbial adhesion 
3. anchorage to the surface by exopolymer production 
4. growth, multiplication and dissemination of the organisms 
SUBSTRATUM 
Figure 1. Formation of biofilm 
1.1.1 Conditioning film deposition 
Prior to being placed within the body, an implantable medical device is a clean, 
sterile surface, often composed of various polymers termed biomaterials. Immediately 
after insertion of the device into the body, the material surface comes into contact with 
body fluids (such as blood, urine, saliva and mucus) around the implant. In the urinary 
tract Tamm-Horsfall glycoprotein, various ions, polysaccharides and other components 
diffuse within minutes toward the implant surface from the bulk urine. [9] 
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Macromolecular components from these body fluids adsorb extremely quickly on to the 
material surfaces to form a conditioning film, prior to the arrival of the first organisms. 
Many of the molecules are proteinaceous, such as serum albumin, fibrinogen, collagen 
and fibronectin, and some have been shown to effect subsequent bacterial adhesion.[10] 
The types of components that will adhere to an implant depend on the surface 
characteristics of the substratum, including its surface chemistry, charge, and 
hydrophobicity. The conditioning film itself may not completely cover the entire implant 
surface but may form a mesh-like covering.[l 1,12,13] Thus, the creation of a conditioning 
film alters the surface characteristics of implants. It is for this reason that many implants 
with altered surface characteristics are ineffective, as mechanisms of preventing microbial 
attachment, including hydrophilic gels and antmicrobial coatings.[14] In vitro, these 
devices are effective in the absence of conditioning film components. However, in vivo, 
the formation of a conditioning film diminishes their efficacy allowing microbial 
adhesion. [15] The diminished efficacy may be a result of binding sites being created by 
film components, allowing microorganisms to adhere and colonise these surfaces. For 
example, the common presence of sodium or magnesium ions in the urine, act as bridges 
between a negatively charged implant surface and negatively charged microbial surface 
(Figure 2). The role of the conditioning film is vital, as many pathogens do not have 
mechanisms allowing them to adhere directly or strongly onto bare implant surfaces. [16] 
Bacterium 
Ca2+ Z -
Mg2+ Mg2+ Ca2+ " 
Ca2+ Mg2 + C a 2 + 
Conditioning 
r — Film 
Substratum 
Figure 2. A bacterium adhering to conditioning film components on a substratum 
via a bridge of positive ions (magnesium and calcium ions). 
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1.1.2 Initial microbial approach and attachment 
The next step in the development of a biofilm is the approach and attachment of 
microorganisms. Several theories have been put forth to explain the complex interaction 
that occurs as a microbe approaches and then attaches to a surface. However, the precise 
mechanisms of attachment to biomaterials are still under study. 
In order for bacteria to react to a surface or an interface like an air-water interface, 
these cells must be able to 'sense' their proximity to these surfaces. The planktonic 'free-
floating' bacterial cells release both protons and signaling molecules as they move 
through the bulk fluid. These protons and signaling molecules must diffuse radially away 
from the floating cell, if not adjacent to any surface or interface. But a significantly higher 
concentration of either protons or signaling molecules can develop on the side of the 
bacterial cell close to any surface. This allows the cell to sense that it is near a surface 
because diffusion is limited on this side. [4] After the planktonic bacterial cell has sensed 
the surface, it may commit to the active process of adhesion and biofilm formation. 
1.1.3 The adhesion process 
There is no single process or theory, which can completely describe microbial 
adhesion. The main reasons for this are the complexities of the microbial cell surface and 
their surrounding environment. According to Busscher and Weerkamp the microbial 
adhesion process consists of steps occurring at various distances from a surface. [16] 
Initially a distance of more than 50nm, only attractive Van der Waal's forces function. At 
this distance the microbial and solid surfaces are too far apart for any recognition of 
surface features, including surface charge, hydrophobicity and appendages. At 10 to 20 
nm from solid surface, the secondary minimum occurs due to electrostatic repulsion 
between the bacterial and solid surfaces. At this stage, adhesion is reversible because no 
true bonds are attaching the bacterium to the solid surface. Hydrophobic interactions are 
needed to remove layers of water from between the bacteria and the solid surface so that 
the microorganisms can reach the solid surface, which allows the bacterium to come close 
to it (<1,5 nm). There, a wide variety of short-range interactions can take place, directly 
attaching the bacterium to the solid surface. [16] These interactions include specific 
receptor-mediated adhesion via bacterial surface appendages. The final result of this 
process is an irreversibly bound bacterium (Figure 3). 
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Figure 3, The adhesion process: at separation distances of >50 nm, only attractive 
Van der Waal's forces occur. At 10 to 20 nm, Van der Waal's and repulsive 
electrostatic interactions influence adhesion. At < 1,5 nm, short range interactions 
can occur, irreversibly binding a bacterium to a surface. 
1.1.3.1 Effect of the microbial cell surface and environment on attachment 
The microbial cell surface plays a crucial role in adhesion. Two factors that have 
been extensively studied are cell surface and hydrophobicity. Studies have correlated 
these cell surface properties in an attempt to predict bacterial adhesion to a wide variety of 
surfaces, including various polymers. [17,18] Factors in the fluid environment can vary 
adhesion profiles that have been based on in vitro experiments. Reid et al and Hawthorn 
at al found that the adhesion of uropathogens to biomaterials in the presence of various 
urinary compounds (including Tamm-Horsfall glycoprotein, urea, and creatinine) as well 
as collected whole urine did not follow any predicted trends based on thermodynamic 
principles. [19,20] Studies by Fletcher and Zheng et al have shown that bacterial 
concentration, time, temperature and flow velocity, all play roles in positively or 
negatively influencing the attachment of microorganisms to surfaces. [21,22] Overall these 
studies indicate that environmental conditions play an important role. Thus, it is 
impossible to make any generalisation of all the possible factors that play a role in 
microbial adhesion to biomaterials. 
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1.1.4 Growth and colonisation 
Following initial attachment, bacteria can begin growth and colonisation to 
establish themselves firmly on a surface. The attached bacterial cells must synthesise new 
exopolysaccharide materials in order to fasten their adhesion to the surface, and to other 
bacterial cells in the developing biofilm, in order to progress from the reversible 
'attachment' stage to the irreversible 'adhesion' phase of biofilm formation. Studies of 
some species prove that the attached cells upregulate all of the genes that produce 
enzymes responsible for the synthesis of exopolysaccharide (EPS) itself and for several 
cell envelope changes.[4] Costerton et al found 30-40% of difference in the important 
protein molecules, when they compared the proteins in the cell envelope fraction of cells 
in the biofilm phenotype, with proteins in the same fraction of planktonic cells. [4] 
Therefore, in at least one organism and probably in most bacteria, bacterial cells that 
attach to a surface at the end of the process of biofilm formation the biofilm cells are 
significantly different from their planktonic counterparts.[23] 
The growth rates of organisms on a surface as well as the strategies used by 
microorganisms to spread over a surface are important for colonisation. These strategies 
are species specific which can influence the distribution of a biofilm on a surface. 
Potential colonisation strategies include mother cells that attach to a surface releasing 
daughter cells, which migrate to another location and become mother cells themselves. 
Another method known as rolling, occurs when a microorganism is loosely attached, so 
that it can roll along the surface as a growing and dividing cell. [24] 
The final stage of microbial colonisation of a surface is the formation of a biofilm 
structure. At this point, the microorganisms have created for themselves a 
microenvironment protective against many antimicrobial agents and host immune defence 
mechanisms. 
Biofilm has been described as having a heterogeneous structure with a rough 
surface. [25] Biofilm consists of groups of microorganisms, sometimes in mushroom-like 
forms, separated by interstitial spaces that are filled with the surrounding fluid (Figure 4). 
[26,27] The microcolony is actually the basic structural unit of the biofilm, similar to the 
tissue which is the basic unit of growth of more complex organisms. Depending on the 
species involved, the microcolony may be composed of 10-25% cells and 75-90% EPS 
matrix.[4] The biofilm contains 'water channels' which allow transporting of essential 
nutrients and oxygen for the growth of the cells. [28] 
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In summary, the biofilm is usually built up of three layers (Figure 5) [29]: 
1. the linking film which attaches to the surface of tissue or biomaterials 
2. the base film of compact microorganisms 
3. the surface film as an outer layer, where planctonic organisms can be released 
free-floating and spreading over the surface. 
BASE FILM 
P.P.N.P.III.ONJNG FILM 
SUBSTRATUM 
SURFACE FILM 
Figure 5. Composition of biofilm 
1.2 Antimicrobial susceptibility of bacteria living in biofilm 
The use of antibiotics is currently one of the possibilities of the prevention of 
biofilm formation. However, even in the presence of antibiotics, bacteria can adhere, 
colonise, and survive on implanted medical devices, as has been shown for urinary 
catheters and ureteral stent surfaces in vitro and in vivo. In addition, resistance to 
antimicrobial agents and other chemicals is one of the greatest problems in the age of 
widespread use of medical devices. The problem in conventional clinical microbiology is 
how best to treat patients based on bacterial cultures from samples derived from 
planktonic free-floating bacterial cells, which are very different from bacteria in the 
biofilm mode and are responsible for the clinical failure rate of treating chronic bacterial 
infection. 
The failure of antimicrobial agents to treat biofilms has been associated with a variety of 
mechanisms [30-34] : 
/ f Y.&yete 
\ 
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- One mechanism of biofilm resistance to antimicrobial agents is the failure of an 
agent to penetrate the full depth of the biofilm (extrinsic resistance). The matrix of 
a biofilm can delay the diffusion of antibiotics. 
- The growth rates of bacteria within a biofilm vary widely. Slow-growing bacteria 
are particularly resistant to antmicrobial agents. In general, the faster growing, 
more susceptible bacteria lie more superficially, with the slow-growing less 
susceptible bacteria being placed more deeply. The failure of antimicrobial agents 
to eradicate these slow-growing bacteria may force selection pressure on the least 
susceptible genotype to select for a resistant population. Furthermore, 
antimicrobial binding proteins are poorly expressed in the slow-growing bacteria, 
making the antimicrobial agents ineffective. 
- Bacteria within biofilm are phenotipically so different from their planctonic 
counterparts that antimicrobial agents developed against the latter often fail to 
eradicate organisms in the biofilm. Bacteria within a biofilm activate many genes 
which alter the cell envelope and molecular targets and the susceptibility to 
antimicrobial agents (intrinsic resistance). Current opinion is that phenotypic 
changes caused by a genetic switch, when approximately 65-80 proteins change, 
play a more important role in the protection from antimicrobial agents than the 
external resistance provided by the exopolysaccharide matrix. 
- Bacteria within a biofilm can sense the external environment, communicate with 
each other and transfer genetic information and plasmids within biofilm. 
- Bacteria in a biofilm can usually survive the presence of antmicrobial agents at 
concentrations 1000-1500 times higher than the concentrations that kill plankton 
cells of the same species. 
1.3 Catheter-associated infections 
Millions of urethral catheters are used annually in acute care hospitals and nursing 
homes across the world. According to a multicentre prevalence study carried out in eight 
European countries, 11% of hospital patients were undergoing indwelling bladder 
catheterization.[35] Another study in Denmark found that 4,9% of patients in nursing 
homes and 3,9% of those in home care were catheterised.[36] 
Urethral catheters are widely used to provide temporary relief of anatomic or 
physiologic obstruction, to facilitate surgical repair of the urethra and surrounding 
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structures, to provide a dry environment for comatose or incontinent patients and to 
permit accurate measurement of urine output in severely ill patients. Unfortunately the 
urethral catheter is the most prevalent cause of nososcomial urinary tract infections 
(NUTI) and gram-negative bacteremia. 
In the process of endourological development a great variety of foreign bodies 
have been invented besides urethral catheters like ureter stents and percutan nephrostomy. 
Although the tendency of foreign bodies to predispose patients to infections has been 
recognised since the fourteenth century, the mechanisms of device related infections are 
still not completely understood. 
1.3.1 Incidence of catheter- associated urinary tract infections and epidemology 
The presence of an indwelling urethral catheter bypasses normal host defences 
allowing continuous access of organisms into the urinary bladder and markedly increasing 
the frequency of urinary tract infections. The duration of catheterization is the most 
important risk factor for development of catheter-associated bacteriuria. The risk of 
infection with a single catheterization is 1-2%. The risk of new infection can arouse 3 
to7% a day in catheterised patients while the catheter remains in situ and almost all the 
patients will be bacteriuric by the end of the 30th day. Other important risk factors are as 
follows [37,38]: 
1. microbial colonisation of the drainage bag and periurethral area 
2. diabetes mellitus 
3. female patients 
4. absence of use of urinometer 
5. absence of antibiotic use 
6. indications other than surgery or output measurement 
7. compromised status of renal function 
8. errors in catheter care 
9. abnormal serum creatinine 
10. periurethral colonisation with uropathogens. 
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1.3.2 Pathogenesis of device-related infection 
Device-related infection results from the multifarious interaction of bacterial, 
device and host factors. Of these 3 factors, bacterial factors are probably the most 
important in the pathogenesis of device-associated infection, whereas device factors are 
the most amenable to modification with the objective of preventing infection. 
1.3.2.1 Bacterial factors 
Bacteria can adhere to almost any surface. The mechanism by which bacteria 
adhere to tissues or implant surfaces is mediated by bacterial adhezins that are located 
either on filamentous appendages called fimbriae or directly on the bacterial surface. 
Adhesion permits the bacteria to resist being washed away by the flow of urine in the 
urinary tract and is a necessary pre-condition to growth, colonisation and subsequent 
infection. [28,4] Different bacteria use different adhesions to colonise medical devices. 
Many examples of the role of bacterial adherence to the device have been reported in the 
literature, and specific bacterial adherence to the device has been shown to be 
characteristic of many pathogenic microorganisms. For example, Providencia stuartii is 
more prevalent in the urinary tract of patients with long-term catheters than it is in 
catheter-free patients. Persistent adherence of Providencia stuartii to urinary catheters is 
thought to be mediated by type 3 fimbriae on the basis of the following observations [39]: 
bacterial isolates that caused long-term (>12 weeks) bacteriuria expressed type 3 
fimbriae more than the isolates that caused short-term (<1 week) bacteriuria (74% 
v. 26%, respectively) in catheter dependent patients 
bacterial isolates that expressed type 3 fimbriae bound in higher numbers to 
catheters than the isolates that did not express type 3 fimbriae 
bacterial isolates that expressed type 3 fimbriae bound less to Tom Harsfall 
protein (an inhibitory protein) than the bacterial isolates that did not express type 
3 fimbriae. 
Similarly, despite the overabundance of data on the adherence of Escherichia coli to the 
uroepithelium, relatively little is known about adherence of this organism to urological 
devices. Escherichia coli isolates that caused long-term (>12 weeks) bacteriuria expressed 
type 1 fimbriae more than isolates that caused short-term (<1 week) bacteriuria (92% vs. 
59% respectively). [40] 
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1.3.2.2 Device factors 
The presence of the device can enhance bacterial virulence. Careful analysis of the 
data on bacterial adherence and surface modification of the device yields the following 5 
major principles: 
1. Different bacteria may adhere differently to the same device material. 
2. The same bacteria may adhere differently to different device materials. 
3. The same bacteria may adhere differently to the same device material placed 
under different circumstances, including the medium in which the device is 
placed (hydrophobic vs. hydrophilic medium), type of flow (dynamic vs. 
stationary), and temperature. 
4. In vitro inhibition of bacterial colonisation of the device does not ensure anti-
infective efficacy in vivo. 
5. The clinical benefit of a particular surface-modifying approach may vary from 
one application to another. Notwithstanding these 5 major principles, there are 
a number of device-related factors that can affect bacterial adherence to the 
device, including the source of device material, surface of the device, and 
shape of the device (Table 1). 
Type of device material: 
Polyvinyl chloride favours bacterial adherence more than teflon 
Polyethylene favours bacterial adherence more than polyurethane 
Latex favours bacterial adherence more than silicone 
Silicone favours bacterial adherence more than polytetrafluoroethylene 
Source of device material: 
synthetic favours bacterial adherence more than biomaterial 
Surface of device: 
Irregular favours bacterial adherence more than regular 
Hydrophobic favours bacterial adherence more than hydrophilic 
Shape of device: 
Polymeric tubing favours bacterial adherence more than wire mesh 
Table 1. Device-related factors that may favour bacterial adherence 
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1.3.2.3 Host factors 
These factors can be divided into 2 groups [4]: 
1. host factors that can affect bacterial adherence of the bacteria to the device, 
including tissue ligands that can mediate adherence of some bacteria 
2. host factors that can either promote or inhibit the persistence of already adherent 
bacteria on the surface of the device 
1.3.3 Pathogenesis of catheter-associated infection 
The ways in which bacteria infect the catheterised bladder are well established. 
Bacteria can enter the urinary tract in catheterised patients in three ways [37,41-43]: 
- Introduction of organisms into the bladder at the time of catheter insertion: 
This is especially common in patients who may have inadequate cleaning of the 
perineum and distal urethra. 
- Periurethral route: This route of entry is especially important in catheterised 
women. Organisms colonising the periurethral epithelia and skin can enter the 
urinary tract via external surface of the catheter in the mucous sheath between the 
catheter and urethral mucosa. 
- Intraluminal route: In males the predominant route is intraluminal, suggesting an 
exogenous source. Microorganisms can ascend through the lumen of the urinary 
catheter into the bladder. Nickel et al demonstrated in their experimental work that 
the intraluminal ascent of bacteria is faster (32-48 h) than the extraluminal route 
(72-168 h). Bacteria contaminating the drainage system can also gain access to the 
bladder through the lumen of the catheter. The taps of the urine drainage bags 
commonly become contaminated during use and their regular opening to drain the 
urine also affords the bacteria access to the bags. Bacterial multiplication in the 
urine produces dense populations of contaminating organisms in the bags and 
from these reservoirs of infection can migrate to the drainage tube, the catheter 
and bladder. Disconnection of the catheter from the drainage tube has also been 
shown to lead to contamination of the system. In wards where high standards of 
catheter hygiene are not maintained, the spread of organisms to the bladder via a 
contaminated drainage system will be the more significant and rapid route. 
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1.3.4 Microbiology of catheter-associated infection 
Most episodes of short-term catheter-associated bacteriuria are asymptomatic and are 
caused by single organisms. The most common species is E.coli. Other common 
organisms are Pseudomonas aeruginosa, Klebsilella pneumoniae, Proteus mirabilis, 
Staphylococcus epidermidis, and Enterococcus spp. and Candida species. [37,42,43] The 
patient with a long-term indwelling catheter is at high risk of morbidity due to this 
procedure. With prolonged catheterization of 10 days or longer, bacteriuria with at least 
one bacterial strain is common. But most patients have at least 2 bacterial strains. The first 
common uropathogene is E. coli and the second is another kind of organism, namely 
Providencia stuartii which is rarely found outside the catheterised urinary tract. 
Pseudomonas aeruginosa, Proteus mirabilis, Morganella morganii, Acinetobacter 
however, can occur as well.[37,42,43] These phenomena result in polymicrobial 
bacteriuria in up to 95% of urine specimens from long-term catheterised patients. During 
long-term catheterization, besides symptomatic UTI, we can frequently observe 
encrustation and blockage of catheters. 
1.3.5 The structure and features of catheter biofilms 
Using scanning electron microscopy, Nickel observed that the external and 
luminal surfaces of catheters removed from patients with symptomatic Pseudomonas 
aeruginosa urinary tract infections were heavily colonised by viable bacteria built into an 
extensive polysaccharide matrix. [44] Subsequent studies have revealed that catheters are 
commonly colonised, particularly on the luminal surfaces by these bacterial biofilms. 
Ohkawa et al also observed that the surfaces of catheters removed from patients after just 
1-3 days were coated by fibrinogen. [45] They suggested that this proteinaceous layer 
originated from host tissues injured during catheterization and initiated biofilm 
colonisation. Ganderton et al found biofilms on 44 out of 50 catheters that had been 
indwelling from 3 to 83 days. [46] They extended along the whole length of the catheters, 
and bacteriological analysis revealed the presence of Pseudomonas aeruginosa of luminal 
surface area. It was shown that after inoculation of the species, biofilm developed locally 
within a lag phase of 2 hours, then the biofilm ascended very rapidly within the lumen 
against the urine flow in the creep phase (l-2cm/h). Biofilm has also been seen 
throughout catheter drainage systems. The surfaces of the drainage bag taps, the internal 
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surfaces of the drainage bags, the 'non-return' valves of the drainage tubes can all become 
colonised by bacterial biofilm. Nickel and co-workers presented evidence from 
laboratory, experimental animal and clinical studies that the adherent biofilm can initiate 
bladder infections by creeping from the drainage tap into the bag and from there 
progressing along the internal surfaces of the drainage system and catheter. [47] It is also 
probable that the columns of urine that develop in the drainage tubes above the bag 
facilitate the ascent of bacteria towards the catheter. 
Bacterial biofilm can even develop on ureteral stents that are lying completely 
within the urinary tract (Figure 6 a, b, c). Reid at al found that 90% of indwelling silicone 
double J stents were colonised by adherent bacteria, however the incidence of urinary 
infection detected clinically was only 27%.[48] But 45% of adherent pathogens were 
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present in low numbers (10 -10 per 1 cm ) and 55% were in small and large microcolony 
biofilms ( > 2 x l 0 2 - 107). The isolated organisms were Gram-positive cocci (77%), Gram-
negative rods (15%) and Candida sp. (8%). The difficulty in detecting biofilm formation 
by using conventional laboratory procedures was confirmed in a large study of 237 
ureteric stents in which it was shown that 68% of stents were actually colonised but only 
30% of patients were found to have bacteriuria.[49] Therefore, a negative urine culture 
does not rule out the possibility that the stent itself is colonised. In the study there was a 
correlation between the duration of stent implantation and infection. 
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c. 
Figure 6 a, b, c. Scanning electron microscopy picture of a developing biofilm 
(Pictures are taken during our own studies.) 
1.3.5.1 The role of biofilms in the encrustation and blockage of catheters 
An additional problem of medical biomaterials in the urinary tract environment is 
the development of encrustation and consecutive obstruction. When the drained urinary 
tract becomes infected by urease producing bacteria such as Proteus mirabilis, the 
bacterial urease generates ammonia from urea and elevates the pH of the urine. The 
enzyme urease from Proteus mirabilis hydrolyses urea six to ten times faster than the 
urease enzymes from other species (Morganella morganii, Providencia stuartii, 
Klebsiella pneumoniae, Proteus tettgeri, and Proteus vulgaris). In the alkaline 
environment, crystals of magnesium ammonium phosphate (struvite) and calcium 
phosphate (hydroxyapatite) are formed and trapped in the organic matrix surrounding the 
cells.[50,51] Progression of these encrustations eventually blocks the catheter lumen 
(Figure 7 a, b, c, d). Examination of these infection-induced stones by scanning electron 
microscopy confirmed the presence of microbial cells throughout their structure. 
Similarly, the scanning electron microscopy study of Cox et al showed the presence of 
large numbers of bacilli associated with catheter encrustations and substantiated the view 
that they are generated by the process responsible for the formation on infection-induced 
stones. [52] It is now clear that catheter encrustations are mineralised bacterial biofilms. 
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Bacteriological analysis has confirmed that the urease producer Proteus mirabilis is the 
predominant organism in encrusted catheter biofilms.[53] While urease is the main 
driving force behind mineralization of the biofilm, there is evidence that the bacterial 
capsule polysaccharide is also involved in the process. In vitro studies have indicated that 
the capsule produced by Proteus mirabilis creates a gel which stabilises the growing 
crystals and that the purified exopolysaccharide from the capsule was capable of binding 
magnesium and accelerating struvite formation.[54,55] McLean et al observed that the 
first stage in the process was the deposition of organic material on the test surface.[53] 
Crystals of struvite then started to form slowly on this conditioning film. Aggregates of 
cells attached to the surface and growth of these cells produced microcolonies that 
eventually developed into complete biofilm. Crystals of struvite then formed rapidly in 
the biofilm matrix. Stickler et al used a simple physical model of the catheterised bladder 
to produce encrusted catheters. Transmission electron micrographs of sections through the 
mineralised biofilms revealed elongate struvite crystals lying in the body of the biofilm 
and also in direct contact with catheter surface, where they had obviously become heavily 
colonised bacteria. The amorphous calcium phosphate particles were seen distributed 
throughout encrusted biofilms and many of them appeared to have formed around 
bacterial cells. These observations suggest that in catheterised patients infected by 
Proteus mirabilis, bacteria and crystals present in the urine adhere to the luminal surface 
of the catheter. Further colonisation and growth of the cells on catheter and crystal 
surfaces produces the alkaline biofilm, which provides the conditions for continued 
encrustation and catheter blockage. 
Figure 7. Encrustation blocks the lumen of the catheter 
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In summary, the current evidence suggests that catheter encrustation is brought about by 
the infection of the urinary tract by Proteus mirabilis or other urease-
producing species 
the formation of an organic conditioning layer on the catheter surface 
the adherence of bacterial cells onto the catheter 
multiplication of the attached cells and the development of the 
biofilm community within a polysaccharide matrix 
the elevation of the pH of the urine and the biofilm by the action of 
urease on urea 
the attraction of calcium and magnesium ions from urine into matrix 
the gel-stabilised crystallisation of calcium and magnesium 
ammonium phosphates. 
Clinical experience and laboratory studies have shown that all types of catheters 
currently available are vulnerable to blockage by crystalline Proteus mirabilis 
biofilms.[37] The complications resulting from catheter encrustation seriously 
compromise patient care. The crystalline deposits can be hard and abrasive and can 
traumatise the bladder mucosa and urethra. Obstruction of urinary flow through the 
catheter may cause either incontinence due to leakage of urine around the catheter or 
painful distension of the bladder due to urinary retention. Bacteriuria is always found in 
these patients, so retention and vesico-ureteral reflux may facilitate ascending infection of 
the urinary tract, culminating in episodes of pyelonephritis, septicaemia and shock. Thus, 
undetected catheter blockage may lead to life-threatening complications. Several studies 
have reported that up to 50% of patients undergoing long-term catheterization will require 
unscheduled catheter replacement because the flow of urine has been blocked by 
crystalline deposits. [42] Cools and Van der Meer, for example, recorded that only 18% of 
catheters in nursing homes were replaced according to a once-a-month protocol.[56] In all 
other cases, early unscheduled replacement was necessary because of obstruction, 
persistent leakage around the catheter or removal of the catheter by the patient. Kunin et 
al characterised nursing home patients with catheters as 'blockers' or 'non-blockers', 
defining blockers as individuals whose catheters became totally clogged or grossly 
occluded, leaving only a narrow channel for urine. They reported that 55% of long-term 
catheterised patients were blockers.[57] Getliffe found that 43% of the population of 
catheterised patients being cared for in the community suffered from recurrent catheter 
encrustation and that catheter status was significantly associated with female sex and poor 
24 
mobility. [5 8] Kunin, in attempting to identify patients at special risk of developing 
catheter encrustations, found no significant differences between blockers and non-
blockers with respect to age, activities of daily living and mental status. [59] Examination 
of the constituents of urine revealed no significant differences between the two groups for 
protein, sodium, calcium, potassium, chloride, uric acid, oxalate and osmolality. Blockers 
excreted more alkaline urine containing less magnesium, urea and phosphate. They were 
also more often colonised by Proteus mirabilis and Providencia stuartii than non-
blockers. 
Choong at al examined the relationship between urinary pH, UTI and catheter 
encrustation. [60] A large component of catheter encrustation is composed of calcium salts 
and this study focused on the relationship between urinary pH and ionic calcium 
concentration in patients with long-term catheters. The non-blocker group shows that 
there is a wide safety margin between the pH in the bladder (pHv), and the crystallisation 
pH (pH„). The blocker with urease producing organisms group shows that this margin of 
safety has been significantly reduced and therefore, crystallisation and precipitation are 
more likely to occur in this group. The blocker and urease negative group shows that the 
voided pH of the blockers without urease-producing organisms lies within the 
crystallisation zone, which favours encrustation and blockage of the urinary catheters. The 
relationship between urinary pH and Ca2+ concentration markedly different in catheter 
blockers and non-blockers. Non-blockers had a significantly more acidic voided urine pH 
as compared to blockers and did not have urinary infection. Catheter non-blockers had a 
wide safety margin between the voided pH and the value above which crystallisation 
occurred, which was absent in the catheter blockers. Blockers with urease producing 
organisms had nucleation pH values similar to those of non-blockers, the main difference 
being the value of the voided urine pH, which was significantly more alkaline (Figure 8). 
Similarly encrustation of ureteric stents is influenced not only by the shape, 
surface properties and composition of the catheter but also by the physicochemical 
environment in which it is placed. There exist several individual variations among 
patients, irrespective of the type of material used. With identical ureteric stents, some 
patients show no evidence of encrustation and blockage whereas other patients show 
variable degrees of the phenomenon. This implies that encrustation is at least partially 
dependent on the composition of the urine in which the stent dwells. 
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Figure 8. The relationship between the voided urinary pH and pH„ among catheter 
non-blockers and blockers with and without urease activity, 
(adapted from Choong S., Wood S., Whitfield H.F. Catheter-associated urinary tract infection and 
encrustation. Int J of Antimicrobial Agents 2001; 17: 305-310) 
Keane at al examined ureteric stents from 40 patients and identified a profuse 
biofilm on 28% and encrustation on 58% of the stents. [61] They concluded that newer 
materials must be used if effective long-term stenting is to be achieved. Schulze et al also 
reported severe encrustation and stone formation on indwelling ureteric stents in two 
patients with a lithogenic history in the presence of sterile urine.[62] He observed that 
patients who are stone-formers are at an increased risk of stent encrustation. The problem 
of encrustation has been exacerbated by increased use of extracorporeal shock-wave 
lithotripsy (ESWL) in combination with double J stents. These stone-forming patients 
have been shown to develop encrustation rapidly. 
1.3.6 Management of catheter-associated bacteriuria 
Most patients who have bacteriuria immediately after catheter removal have 
accompanying pyuria and are asymptomatic. The majority of bacteriuria will have cleared 
on repeat culture 1-2 weeks later. The optimal antibiotic regimen in this setting is unclear. 
The optimal period of antibiotic treatment varies between 4 to 10 days. For older women, 
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patients with upper tract symptoms and males certain authors favour 10 to 14 days of 
antibiotic treatment. In patients who have been catheterised for short period of time urine 
culture should be obtained at the time the catheter is discontinued or within 24 to 72 hours 
of the event. 
Antibiotic irrigation of the catheter or bladder does not appear to be as effective as 
closed drainage any more.[43] Asymptomatic bacteriuria should not be treated as long as 
the catheter remains in place. Because complications of long-term catheterization are 
primarily infectious in nature, treatment during catheterization is not helpful in 
eradicating infection for prolonged periods of time and serves only select populations of 
organisms that are resistant to the antibiotics being used. There are some exceptions 
[7,37,42]: 
a) when therapy is part of a plan to control infections by particular organism in 
medical unit 
b) patients who have a high risk of serious complications (e.g. granulocytopenic 
patients, pregnant women) 
c) patients undergoing urologic surgery or prostheses implantation 
d) patients with recurrent obstructions of the catheter which are mostly associated 
with infections by Proteus mirabilis. 
Generally after the catheter is removed the urinary tract will clear bacteria 
spontaneously. Among catheterised-patients dysuria, pain, irritative symptoms are not 
significantly different between those who develop bacteriuria and those who do not. 
However, in some cases catheter-associated complications can develop. 
Systemic antibiotics should be used for catheterised patients who are febrile and ill-
appearing, presumably for UTI, with signs or symptoms suggesting a possible UTI-related 
bacteremia. Causes for fever other than the urinary tract have to be evaluated and 
catheters are assessed for partial or complete obstruction. The patient is examined for 
periurethral complications of urethral catheterization. Urine and blood cultures are 
performed. Catheters should be replaced or removed during the therapy of symptomatic 
catheter-associated bacteriuria because of the likelihood of bacteria sequestered in a 
biofilm on the catheter surface. Definitive antibiotic therapy is to be adjusted based on 
microbial susceptibility studies. If bacteremia is suspected or known, broad-spectrum 
antibiotics are indicated (ampicillin or cephalosporin and aminoglycoside or 
fluoroquinolone), while one is waiting for the results of urine and blood cultures. It is 
advisable to exclude enterococcal bacteraemia by unspun urine gram stain. If urine gram 
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stain shows no gram-positive cocci an aminoglycoside can be used alone. When culture 
results are available, initial empiric therapy can be tailored based on susceptibility data. 
These patients usually require a full 10 to 14-day therapy. The mortality rate of 
nosocomial catheter-associated bacteremia varies between 9-13%.[63] The risk factors for 
death include severity of comorbidities, shock, inappropriate antibiotic therapy, presence 
of infection in other sites and presence of unrecognised urological abnormalities. 
If no bacteremia is suspected or documented, these patients should be treated with short (3 
to 5 days) courses of antibiotics based on susceptibility data. This will usually sterilise the 
urine without selecting more resistant bacteria and may allow a prostatic focus to persist. 
Prolonged therapy can only select out resistant organisms. For patients who have a low-
grade temperature and are clinically stable, observation might be reasonable as the low-
grade temperature may be transient. 
Candiduria may occur in patients depending on the duration of catheterization. It is 
usually asymptomatic and resolves without treatment. In case of complications systemic 
therapy by amphotericinB B or fluconazole is indicated. The chronic antibiotic 
suppressive therapy is not effective because the catheter acts as a foreign body, the urine 
of these patients cannot be sterilised for a prolonged period of time. 
1.3.6.1 The role of antibiotics in the treatment and prevention of catheter-
associated biofilm formation 
In the case of urinary catheters, there is evidence from clinical observations that 
within protection of the biofilm, bacteria defined as sensitive to antibiotics by 
conventional laboratory test procedures can survive the urinary concentrations of 
antibiotics generated by conventional treatment regimens. During an in vitro test Nickel et 
al showed that when strains of Pseudomonas aeruginosa produced biofilms on catheter 
materials they acquired resistance to tobramycin, amikacin, ceftazidime, ciprofloxacin 
and meropenem. [64,65] For example, when tobramycin was added to the artificial urine, 
the lag phase was prolonged for almost 12 hours. Despite antibiotic treatment, biofilm 
developed and ascended the catheter surface very slowly, at a rate of approximately 0,2-
0,3 cm/hour. Goto and co-workers investigated in vitro and in vivo models of catheter-
associated infection, biofilm formation of Pseudomonas aeruginosa in artificial urine and 
bactericidal activity of several classes alone or in combination with macrolide antibiotic. 
[66] According to these studies the beta-lactam antibiotics and aminoglicosids can prevent 
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the formation and the extension of 'young' biofilms in growth. Papipenem showed more 
potent activities than piperacillin and ceftazidime, and 128 times the MBC of amikacin 
showed almost comparable bactericidal activity with that of 64 times the MBC of 
papipenem against Pseudomonas aeruginosa biofilms (Figure 9,10) [66]. On the other 
hand, fluoroquinolones, like for example, levofloxacin and ciprofloxacin were effective in 
cases of both 'young' and 'older' biofilms because the biofilm bacteria were completely 
eradicated by treatment with 64 times the minimal bactericidal concentration (MBC) of 
ciprofloxacin and levofloxacin for 24 h. (Figure 11). However, the effect of 
fluoroquinolones is limited, and it appears that none of the commercially available drugs 
are sufficiently active against the cells in a mature biofilm. There were few combinations 
of antibiotics which showed synergistic activities against P. aeruginusa biofilm. 
Tsukamoto et al studied the clinical effect of ciprofloxacin, which has high antimicrobial 
activity against gram-negative bacteria, in combination with antibiofilm agent 
clarithromycin in complicated urinary tract infection. [67] The study indicated that the 
combination was clinically superior in terms of complete bacterial elimination and clinical 
efficacy in patients without an indwelling catheter. But in patients with an indwelling 
catheter the combination achieved a higher clinical efficacy than ciprofloxacin alone, 
although the complete bacterial elimination rate was not different between the two groups. 
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Figure 9, Time-kill curves of piperacillin and ceftazidime against the biofilm 
bacteria of P, aeruginosa 
(adapted from Goto T., Nakame Y., Nishida M . , Ohi Y. Bacterial biofilms and catheters in 
experimental urinary tract infection. Int. J of Antimic. Agents 1999; 11: 221-231.) 
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Figure 10. Time-kill curves of papipenem and amikacin against the biofilm bacteria 
of P. aeruginosa 
(adapted from Goto T., Nakame Y., Nishida M . , Ohi Y. Bacterial biofdms and catheters in 
experimental urinary tract infection. Int. J of Antimic. Agents 1999; 11: 221-231.) 
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Figure 11. Time-kill curves of ciprofloxacin and levofloxacin against the biofilm 
bacteria of P. aeruginosa 
(adapted from Goto T., Nakame Y., Nishida M . , Ohi Y. Bacterial biofilms and catheters in 
experimental urinary tract infection. Int. J of Antimic. Agents 1999; 11: 221-231.) 
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1.3.7 The control of catheter encrustation 
A variety of methods are currently used to try and control the problem of catheter 
blockage. These include simply replacing the blocked catheter, changing the type or size 
of catheter, antibiotic treatment of the associated urinary tract infection, increasing the 
patient's fluid intake, dietary acidification of the urine and the instillation of 
acidic/antiseptic or saline solutions through the catheter into the bladder (bladder 
washouts). Simply replacing blocked catheters generally results in the rapid encrustation 
of the new catheter. Bladder instillations of acidic solutions designed to neutralise the 
urine and dissolve the calcium and magnesium salts are commonly used. In vitro 
examinations from Getliffe et al showed that it is possible to dissolve urinary catheter 
encrustations even using small volumes of acid bladder washout solutions.[68] It is true 
that struvite formation is reversible. Exposure to undersaturated urine or acidification 
leads to rapid dissolution of this mineral. McLean et al however, found in their flow-cell 
that whereas acidification of the urine medium readily dissolved struvite crystals that 
were in urine suspension, crystals entrapped within the biofilm remained intact. [69] A 
clinical trial in elderly female patients undergoing long-term catheterization also showed 
that bladder washouts had no demonstrable effect on the amount of encrustation occurring 
in vivo. [70] One has to consider that the activity of urease is dependent on the pH of the 
urine. The urease of Proteus mirabilis has its highest activity at a pH of 7. With rising pH 
the activity is reduced and reaches levels of only 50% at a pH of 9. Bibby and Hukins 
demonstrated that the acidification of the urine is not a feasible method for preventing 
encrustation of indwelling urinary catheters. In their experimental work, the acidification 
of the artificial urine in the presence of urease resulted in an initial decrease of pH.[71] 
This decrease in pH was followed by a rapid alkalinization of the urine despite a further 
supply of the acidic agent. This counteraction can be explained by an increase of urease 
activity in more acidic pH, so that further urea was converted into ammonia. Dilute acid 
solutions can remove the protective surface layer of mucus in the bladder and increase 
exfoliation of bladder mucosal cells, so that it should not be used clinically for bladder 
washouts. In contrast, there is evidence that alkaline citrate therapy can delay urease-
induced crystallisation, and prevents residual fragment growth or re-aggregation after 
extracorporeal shock-wave lithotripsy. An antiseptic bladder washout containing 
chlorhexidine produced only minor and temporary effects on Proteus mirabilis infections 
in vitro. 
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Oral intake of ascorbic acid is commonly used as an alternative way of acidifying 
urine. It is clear, however that large doses are required to produce any appreciable 
reduction in urinary pH and that if the urine is already infected with Proteus mirabilis, no 
reduction in the urinary pH is achieved. [72] Urinary acidification alone to prevent 
catheter encrustation can not be recommended routinely at present, as controlled trials are 
lacking in this field. 
High fluid intake is frequently recommended for catheterised patients but, in practice, it is 
difficult to maintain a high diuresis over a prolonged period by increasing water intake 
and urinary solute concentration is not correlated with the degree of encrustation. 
Inhibitors of urease such as acetohydroxamic acid and flurofamide are much more 
effective in lowering pH in Proteus mirabilis-inkcted urine. Clinical trials with 
acetohydroxamic acid have demonstrated that it significantly inhibited the growth of 
struvite stones. Tremulousness and phlebotrombosis were experienced by some patients 
taking the drug and in one study these side-effects were judged intolerable in 22% of the 
patients taking the urease inhibitor. [73] 
1.3.7.1 Modification of catheter material or composition 
Urinary catheters are composed of various materials including rubber, latex, 
silicone, latex and silicone combination with or without hydrophil coating. The local host 
inflammatory response and tissue necroses associated with catheter use are greatest with 
natural rubber, less with latex and minimal with silicone catheters. Latex catheters are the 
least expensive but irritation and allergic reaction may occur. Silicone catheters offer no 
advantage over latex, although they are more comfortable and might be a better choice for 
long-term (>5 days) use. Silicone catheters obstruct less often than latex. Teflon or 
silicone-coated latex catheters in patients prone to catheter encrustation. [74] 
The goal of modification of catheter material is as follows: 
- to prevent bacterial adherence 
- to inhibit bacterial growth 
- to delay the onset bacteriuria 
- to delay or prevent encrustation or blockage 
Different strategies have been tried like for example, the incorporation of biocides 
or antibiotics into the catheter material or development of materials with surface 
properties, which prevent the adherence of bacterial cells. [74] Both active and passive 
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surface modifications can create a less infectious surface. The bactericidal surfaces are in 
reality employing controlled release of antiseptics or disinfectants. A thin layer of 
polymer matrix that covers the biomaterial surface directs the controlled drug-release 
approach. The mechanisms of drug release include diffusion, erosion of polymer matrix 
and dissociation of ionic coupling. 
Concerning incorporation of biocides or antibiotics into catheter material, Nitrofurazone 
was examined in two clinical studies and they showed a one-week limited effect, mainly 
for Gram-positive and some susceptible Gram-negative organisms.[37,42] In vitro study 
combination of minocycline or rifampicine showed some protective effect. Recent multi-
center control trials justified a delayed effect of post-prostatectomy bacteriuria for up to 
two weeks but this protective effect was limited to Gram-positive bacteriuria and thus 
could permit selection of gram-negative microorganisms as well as the development of 
resistant strains. Current efforts are made to incorporate ciprofloxacin into gels to achieve 
slow sustained release of agents. 
In conclusion, catheters impregnated with antimicrobial agents have little effect in 
long-term patients. They can only be effective in short-term patients, especially under 
intensive care.[37,42,75] 
Strategies to achieve the goal of bacteriostatic catheters involve coating or 
impregnation of the catheter material with various compounds. Catheters that are coated 
with silver oxide may delay bacteriuria during short-term use, but silver alloy-coated 
catheters seem to be more effective. The possible working mechanism is that silver 
surface precipitates membrane proteins of surface-associated bacteria to inhibit 
microorganism colonisation. On the other hand, silver ions bound to murein, produce 
bacteriostatic effects whereas at higher Ag+ concentrations, bactericidal effects are 
achieved by silver. [76,77] 
In 1984, Hayward and Chapman suggested that biomaterials coated with lipids 
like those located on the external surface of erythrocytes would be haemocompatible and 
thus, suitable for use in the manufacture of medical devices. [74] It was proposed that 
phosphoryl-choline (PC), the major polar head group on the outer surface of erythrocytes, 
should be incorporated into synthetic polymers to mimic the naturally occurring 
membrane lipid dipalmitoylphosphatidylcholine (DPPC). Due to their poor mechanical 
properties, these polymers were not suitable as the base material for the manufacture of 
medical devices, but they have been exploited as surface coatings. It has been suggested 
that water molecules bind tightly to the PC head groups making it difficult for proteins 
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and other materials to interact with the surface. Indeed, it has been shown that proteins 
exposed to PC surfaces remain in their native state, whereas exposure to the base 
polymers induces conformational changes, which allow the proteins to bind irreversibly 
as a conditioning film. [74] 
According to Stickler in vitro examinations the PC-coating didn't significantly 
reduce the encrustation of either latex or silicone. But the amount of encrustation on the 
PC-coated silicone was significantly less than on PC-coated latex catheters. Nevertheless, 
the mean blockage time of the PC-coated silicone catheter (64 h) was significantly longer 
than that for the latex catheters. In vivo examinations of PC-coated ureteral stents showed 
a lower rate of encrustation (mean encrustation score 1,64 v. 1,92) and biofilm formation 
(36% v. 54%) comparing to uncoated ones.[74] 
Heparin with its antithrombogenicity and its strong electronegativity that repels 
cellular organisms is an excellent candidate for an anti-adhesive stent coating. In 1987 
Ruggieri showed a 90 % reduction of bacterial adhesion on urinary catheter surfaces by 
heparin coating. [78] Hildebrandt demonstrated the reduction of stent encrustation by 
heparin coating in an experimental setting. [79] 
Electric current applied to the catheter surface has been effective in vitro and 
animal model, but a practical clinical application of this technology awaits further studies. 
1.3.7.2 Catheter cares 
The following guidelines may be useful in decreasing or minimising the risk of 
infections: 
catheters should be used only when absolutely necessary 
insertion of the catheter should be performed under antiseptic conditions 
to minimise urethral trauma the tip should be lubricated and the smallest 
possible catheter size should be used 
all indwelling catheters should be attached to closed drainage 
maintain adequate urine flow at all times 
gravity drainage should be maintained 
after the catheter has been removed, a follow-up urine culture should be done 
symptomatic or persistent bacteriuria should be treated 
catheter change is suggested every 2-3 weeks. 
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2. AIMS OF THE STUDY 
1. To examine the predisposing factors of urinary tract infections and septicaemia in 
patients with urinary foreign bodies. To define the strategies of preventive 
treatment with the help of which we can decrease the number of symptomatic 
urinary tract infections in patients with indwelling urinary catheters. To investigate 
the most frequent pathogens on urological devices. 
2. To determine biofilm formation and the development of encrustation on the 
surface of urinary catheters. 
3. To examine the advantages of heparin coating as one of the preventive 
possibilities of biofilm formation and encrustation on foreign bodies (indwelling 
urethral catheters, double J stents and percutan nephrostomy). 
4. To compare the times of developing obstruction as a result of encrustation on 
different catheter materials. To determine the advantages of heparin coating 
concerning the safety of the indwelling time. 
5. To define the adsorption of oral levofloxacin as the 3rd generation of 
fluoroquinolones to ureteral stents. To examine the adsorption level of antibiotics 
on stent conditioning films and their surfaces. To observe antibiotic level on stent 
surfaces after interrupting antibiotic treatment so that we can justify the grounds of 
intermittent or "pulse treatment" strategies. 
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3. MATERIALS AND METHODS 
3.1 Methods used to investigate the predisposing factors of the urinary tract 
infections of patients with J ureteral stents 
From January 2000 to October 2002, 56 patients were included into this study. 
They were inserted double J-stents with the aim of the resolution of obstructions. Before 
the stent insertion and on the day of the stent removal samples of midstream urine were 
obtained from each patient and submitted for microbiological investigation. Stents were 
removed in the operating room under aseptic conditions. At removal 2 to 3 cm of the J 
stent tips located inside the bladder were cut and sent for microbiological culture. Age, 
sex, previous medical history and the indication of the stent insertion were recorded for 
each patient. Single dose 500mg ciprofloxacin antibiotics were given to all patients at the 
time of the insertion for prophylaxis. Patients who had symptomatic urinary tract infection 
during the study were treated by antibiotics based on susceptibility results. In those cases 
where the symptomatic urinary tract infection failed to respond to appropriate antibiotics 
or who had progression to septicaemia the stent was removed. We excluded the patients 
from the study, if they used any antibiotics or immunsupressive drugs in the preceding 
week of the enrolment or simultaneous bilateral double J stents or when anterograd 
insertion was required. A Cook silicone 7Ch ureteral stent was used in all cases inserted 
in retrograde way. 
Chronic renal failure was defined as serum creatinine elevated to above 200 
pmol/1. Diabetic nephropathy was defined as a long-standing history of diabetes mellitus 
with features of chronic renal failure including macro albuminuria. 
Urinalysis was performed in all urine samples using an automated Miditrone 
machine and those with high cell counts were confirmed by the standard manual method. 
The urine and stent tip samples were cultured routinely on eosin-methilen blue agar and 
blood agar, and incubated in air at 37 
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simulations with 100 000 replications were applied. A result of a statistical analysis was 
considered statistically significant if the result did not exceed the value of 0,05. 
3.2 Methods used to prevent the urinary tract infections of patients with J ureteral 
stents 
The most promising method of the prevention of infections connected with urinary 
catheters is the selection of the best catheter material that can resist to biofilm formation. 
Concerning vein catheters, heparin coating proved to be one of the most effective coating 
materials. Therefore we decided to examine the effectiveness of heparin coating materials 
in the urinary tract. 
3.2.1. An in vitro examination of the resistance ability of heparin-coated catheters to 
encrustation caused by crystalline P. mirabilis biofilm 
The ability of three catheter types to resist encrustation and blockage by crystal-
generating urine cultures of P. mirabilis isolated from patients encrusted catheters was 
examined in a laboratory model of the catheterised bladder. Catheters (14 French ones) 
were inserted aseptically through a section of silicone tubing. They were attached to a 
glass outlet at the base of the vessel into a 200 ml glass chamber maintained at 37°C. The 
catheter balloon was inflated with water securing the catheter in position and sealing the 
outlet from the vessel 'bladder'. The catheter was then attached to a drainage tube and 
reservoir bag. Sterile pooled human urine was supplied to the bladder via a peristaltic 
pump. Thus, a residual volume of about 30ml was collected in the vessel below the level 
of the catheter eyehole. As urine was supplied to the model the overflow drained through 
the catheter to the collecting-bag. 
The three catheters tested were a latex catheter with hydrophilic coating, a silicone 
catheter and a heparin-coated silicone catheter. After inoculation of the sterilised urine 
with the P. mirabilis strain the organisms were allowed to establish themselves in the 
model for one hour. The peristaltic pump was then switched on and fresh urine supplied 
to the bladder at 0.5 ml per minute. The models were operated until the catheters were 
blocked with encrustation. Low vacuum scanning rastelectron microscopy (REM) was 
performed to visually assess the extent of encrustation at catheter cross sections 1,4, 10 
and 30 cm from the tip. r y % 
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3.2.2 The use of rastelectron microscopy and energy dosing X-ray microanalyser 
The measuring system consists of high resolution surface electron microscope 
(Fa.LEO 1530 VP), with an energy dosing X-ray microanalyser (Fa.EDAX). The 
composition of the studied material was determined by the help of these instruments. By 
rastelectron microscopy electrons are diverted by the surface of the sample. The 
elastically and non-elastically generated primary electrons entering the matrix of the 
sample produce a more complex interacting effect. Depending on the volume, different 
signals can be seen. The most important ones are: 
secondary electrons (SE1 and SE2) give information on structure of the surface and 
topography 
backscatter electrons (BSE) give information on contrast of material and the 
thickness of sample 
X-ray quantums give information on the type and sum of atoms in the sample 
The surface can be studied by low energy secondary electrons (SE1), which meet 
the primary electron rays, but accept these together with backscatter electrons. 
Backscatter electrons are in an elastic interaction with atoms of the sample. Elements with 
high numbers show a strong backscattering, while elements with low numbers play a role 
in the contrast of the sample. The interaction is dependent on the voltage and the density 
of the sample. The larger the energy of the primary electrons, the deeper they penetrate 
the sample material (Figure 12). 
Figure 12. The rastelectron microscope and energy dosing X-ray microanalyser 
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3.2.3 Clinical evaluation of encrustation and biofilm formation on heparin-coated 
ureteral stents and nephrostomy tubes used during short period of time 
In a patented procedure, the interior and external surfaces of commercially 
available polyurethane ureteral stents and silicone nephrostomy tubes were coated with a 
spacer to which heparin was bound in a covalent manner. In a pilot study the encrustation 
of heparin-coated ureteral stents was compared to uncoated polyurethane ones. Twenty 
heparin-coated and 20 uncoated stents were inserted into obstructed ureters in a 
prospective randomised study under sterile conditions and left indwelling for periods 
between 2 and 6 weeks. The stents were then removed under sterile conditions, sealed in 
sterile covers and sent for electron-microscopic evaluation. The average age of the 
patients in the group of heparin-coated stents was 52 while in the group of uncoated ones 
55. Nephrostomy tubes were used in 2 male patients (average age 63 years) with 
permanent bilateral external urinary drainage suffering from frequent encrustation 
obstruction of their silicone catheters that resulted in repeated emergency visits. In these 
patients a heparin-coated and an uncoated nephrostomy tube were used simultaneously for 
either side so that direct comparison of encrustation status was possible. 
3.2.4 Clinical evaluation of encrustation and biofilm formation on heparin-coated 
ureteral stents during extended indwelling times 
In 10 patients, from which 4 were women and 6 men, with the average age of 66, 
who had permanent ureteral stent drainage, heparin-coated stents were left indwelling for 
6-8 months (Group 1). In all patients bacteriuria was demonstrable at the time of heparin-
coated stent insertion, from previous stents. In 3 male patients with uretero-enteral 
anastomosis stricture in an ileal conduit, heparin-coated stents were left for 1 year 
(Group 2). The average age of the patients was 61. 
3.2.5 Comparison of the heparin-coated and polyurethane stents before the 
development of obstruction in the long time period of indwelling stents 
Between November 2001 and February 2004 18 patients were examined 
retrospectively and double J stents were inserted with the aim of definite resolution of the 
obstruction, partly because of the patients' poor general condition or basic disease. Their 
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average age was 67. In 66%. of cases, i.e. in 12 patients, obstruction was caused by 
advanced urological, gynaecological and retroperitoneal malignancy, while 2 patients had 
obstruction because of ureter stricture and 4 patients had obstruction of the ureteropelvic 
junction (UPJ). First, 7Ch Cook polyurethane stents were placed retrogradely under sterile 
conditions and 200mg of ofloxacin was given for antibiotic prophylaxis. From the starting 
point we performed biochemistry, mid-stream urine culture and abdominal ultrasound 
examination. These were repeated every month after the stent insertion. The stents were 
removed in cases when signs of increased obstruction could be detected in empty bladder 
during ultrasound examination or when the patient developed a symptomatic urinary tract 
infection. On the retrieval of the stents al-cm-piece of bladder, ureter and kidney were 
sectioned, put into a 4% glutaraldehyde solution and stored at 4°C for subsequent REM 
analysis. Further 1cm pieces of different parts of the stent were retained for 
microbiological examination of adhered bacteria. The biofilm attached to the stent surface 
was dislodged into 25% Ringer's solution by combination of gentle scraping with sterile 
scalpel blade and ultrasonication, not later than 2 hours after removal. Stent biofilm 
suspension in 3 ml of 25% Ringer's solution was streaked onto chocolate blood agar and 
was incubated for 48 hours at 37°C aerobically and with 5% carbon dioxide enrichment. 
The REM was performed by one operator who evaluated the stent surface for the presence 
of microbial biofilm and encrustation. A biofilm was said to be present any time adherent 
bacteria were identified on the electron micrograph. The encrustation was determined in 
the following grading system: 
Grading of stent encrustation 
0. no encrustation 
1. microscopic deposit on <50% of the stent section 
2. microscopic deposits on > 50% of the stent section 
3. macroscopic deposits on < 50% of the stent section 
4. macroscopic deposits visible on > 50% of the stent section 
Consequently the polyurethane stents were changed to heparin-coated ones 
(Heparius) inl3 patients with a similar follow up. Indications of the removal of the stents 
were similar to the polyurethane ones, however the maximum indwelling time was 
extended to 12 months as long as side effects did not develop (increased obstruction, 
symptomatic UTI). 
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T-test and Wilcoxon-Mann-Whitney test were used for continuous variables in 
between-group comparisons. Chi-Square and Fisher exact test were used for comparison 
of distributions of categorical variables. Due to the small number of observations the 
results of Fisher exact test and Wilcoxon-Mann-Whitney test was considered as more 
appropriate. Paired T-test and Wilcoxon Signed Rank test were used in within-group 
comparisons. 
A result of a statistical test was considered statistically significant if the resulted p-
value did not exceed 0.05. The calculations were performed by SAS (for Windows, Ver 
8.1). 
3.3. The effect of levofloxacin treatment on urinary tract infections caused by 
obstruction 
During the time between January 2002 and February 2004 we examined 24 
patients who had acute urinary infection caused by urinary obstruction. For this reason, 
first we resolved obstruction by inserting a double J stent or percutan nephrostomy (PCN) 
and meanwhile, started antibiotic treatment (levofloxacin lx 5oomg). 50 % of the patients 
were continuously treated by antibiotics till the day of the definitive curative operation 
when the foreign body was removed (Group 1). The other 50 % of the patients were given 
antibiotic treatment, which was stopped on the 7th day after insertion of double J stent or 
PCN. We started antibiotic treatment again on the day of the operation and continued it 
till the day of the removal of the foreign body (Group 2). On the 7th day of antibiotic 
treatment, due to side effects, levofloxacin treatment was abandoned in 4 patients in the 
continuous group, and was followed in the intermittent one. 37,5% of men and 62,5% of 
women in both groups with the average age of 47 in group 1 and 52 in group 2 were 
involved in the study. The cause of the obstruction could be definitely ceased only after 
treating the acute symptoms of the symptomatic urinary infection at the earliest time of 18 
to 21 days, i.e. after the temporary urinary deviation. Obstruction was mainly caused by 
ureteral stone in 100% of cases in the first group and 75% in the second group of patients. 
Another 2 patients had an impact large pyelum stone in the background of the obstruction. 
In both groups of the patients we examined and recorded clinical signs: fever, pain in the 
back, the number of blood leukocytes, complaints of patients with indwelling stents and 
the early (2 weeks after stent removal) and late (6-8 weeks after stent removal) clinical 
and microbiological recovery. We examined the level of levofloxacin in the conditioning 
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film layer and on the stent surface with the help of high-performance liquid 
chromatography (HPLC). HPLC analysis also allowed quantification of the drug within 
the biofilm and showed that the concentration of antibiotic reached the minimum 
inhibitory concentration (MIC). With the help of these data we could predict which 
uropathogenic bacteria would and which would not be able to form a biofilm. . On the 
retrieval of the stents a 3-cm-piece of bladder, ureter and kidney were sectioned, and sent 
for scanning electron microscopy (SEM). The preparates were stored in a 4% 
glutaraldehyde solution at 4°C. We examined biofilm formation and the rate of 
encrustation on 2 cross-sectional and 1 longitudinal pieces of preparation, taken from each 
part of the catheter and SEM was used with the same aim in both groups. 
Chi-Square and Fisher exact test were used for comparison of distributions of 
categorical variables. Due to the small number of observations the results of Fisher exact 
test was considered more appropriate. 
A result of a statistical test was considered as statistically significant if the resulted 
p-value did not exceed 0.05. The calculations were performed by SAS (for Windows, Ver 
8.1). 
3.3.1 The scanning electron microscopy method 
During this kind of examination preparates which were fixed in 4% glutaraldehyde 
solution were washed in 0,1 M Na-cacodylate buffer. Postfixation in 1% 0s04. 
Dehydration in ethanol from 30% to absolute ethanol. Drying on 56°C in thermostat. 
Affixture to the sample holding by Electrodag 915 Silver Paint glue. Coating the surface 
with gold-film by Jeol Jee 4 B type steamer. The samples were examined by OPTON 
DSM 940 on 50-500x magnification. 
3.3.2 Methods of in vivo assessment of levofloxacin in the conditioning film and 
surface of ureteral stents by High-Performance Liquid Chromatography 
The removed devices were stored at -70°C prior to analysis. After thawing, 
different portions of the ureteral stents (kidney tip, bladder tip and ureteral part) were 
sectioned into 2 cm pieces (x 2 for duplication), placed in a test tube and vortexed for 30 
seconds in 1 ml of HPLC water. This step was performed to recover levofloxacin from the 
conditioning film. The washed stent sections were then transferred to a plastic tube, 
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immersed in phosphate buffer saline (pH 5.5) and left on a gyratory shaker (250 rpm) for 
24 hours to leach off the antibiotic from the surface of the stent. This method was found 
to be optimal for eluting the adsorbed antibiotic from the stent surface. 
The resulting eluents were immediately re-refrigerated to -70°C. HLPC determinations of 
the above mentioned two eluents were carried out on the same day, not longer than 5 days 
after the processing of ureteral catheters. 
We used an existing HPLC method developed by Hairui Liang et al after minor in-house 
modifications and validations. Briefly sample preparation involved addition of the internal 
standard (ciprofloxacin) and filtration of the eluents (SPIN-X LC centrifuge tube filter, 
Costar). Separations were performed on Hypersil ODS CI8 column with a pH 3.5 mobile 
phase containing lOmM SDS, lOmM TBAA, 25mM citric acid and 45% ACN. Detection 
was carried out at 293 nm. Data and chromatograms were collected using Euro Chrom 
2000 for Windows software. Antibiotic standards were kindly provided by the 
manufacturers: levofloxacin from Aventis, ciprofloxacin from Bayer. 
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4. RESULTS 
4.1 The predisposing factors of urinary tract infections of patients with J ureteral 
stents 
In literature a large amount of data can be found concerning the predisposing 
factors of urinary tract infections. Hovewer, much less is known about the cases of 
patients who have indwelling urethral catheters and even less about patients with ureteral 
stents. It is still an unsolved question when it is reasonable to use antimicrobial treatment 
in patients with urinary foreign bodies. For this reason during our study we tried to find 
the group of patients with indwelling ureteral stents for whom antimicrobial treatment 
was advantageous. 
4.1.1 Correlation of duration of double J stenting with associated urinary tract 
infections 
Of the 56 included patients 32 (57,1 %) were men and 24 (42,9 %) were women. 
The average patient age was 41 years (range 23 to 83). From the enrolled patients 17 
(30,3 %) had no systemic disease, 29 had cancer of the urinary tract (51,7%), 20 (35 %) 
had obstruction due to cancer, 7 (12,5 %) had diabetes mellitus and 3 (5,3 %) had chronic 
renal failure. Table 2 shows the patient distribution pattern according to sex and systemic 
disease. 
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Group No. Male (%) No. Female (%) Total No.(%) 
Normal 10(58,8%) 7(41,2%) 17(30,3%) 
Urological cancer 16(55,2%) 13 (44,8%) 29 (51,7%) 
Diabetes mellitus 4 (57,1%) 3 (42,9%) 7 (12,5%) 
Chronic renal failure 2 (66,6%) 1 (33,4%) 3 (5,5%) 
Totals 32 (57%) 24 (43%) 56 (100%) 
Table 2. Distribution of patients according to sex and underlying systemic disease 
The indication for stent insertion was a previous lithotripsy in 8 cases (22%), a 
previous endoscopic procedure in 6 (16,6%) and the relief of ureteral obstruction in 22 
(61%). The mean duration of J stent retention was 17 days (range 6 to 198 days). The 
urine cultures were positive (asymptomatic urinary tract infection) in 4 patients (7,14%) 
before stent insertion and in 15 (26,8%) at stent removal. This difference was statistically 
significant p<0,001. 15 out of all the patients with positive urine culture at stent removal 5 
(33%) had a symptomatic urinary tract infection and received appropriate courses of 
antibiotics. One of the 5 patients was normal, while 4 had a systemic disease. Despite the 
adequate antimicrobial treatment 3 had septicaemia requiring premature stent removal. 
All patients who had septicaemia were women and also had diabetes mellitus. The 
bacteriuria rate was in 2 cases (10%) when stents were removed within 30 days and in 13 
(36%) after 30 days (p<0,01). For stents removed within 30 days the positive culture rate 
of the stent tip was 17%. This rate increased to 42% for stents removed after 30 days 
(p<0,01) (Table 3). 
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Stenting 
duration 
(days) 
No. Pts. 
(%) 
No. Pos. Urine 
Cultures 
(%) 
P.Value 
(Chi- square) 
No. Pos. Stent 
Tip Cultures 
(%) 
P.Value 
< 30 day 18(32%) 2 (10 %) 
p<0,01 
3 (17%) 
p<0,01 > 30 day 38 (68%) 13 (36%) 15 (42%) 
Table 3. Correlation of duration of double J stenting with positive cultures 
4.1.2 Relationship of underlying systemic disease with rate of positive urine and 
double J stent cultures 
Table 4 shows the relationship of underlying systemic diseases with the positive 
urine and stent tip culture rates. In almost all groups of patients the rate of J stent 
colonisation was higher than the rate of positive urine culture but the differences were not 
statistically significant. 
Group No.Pts. No. Pos. Urine No. Pos. Stent Tip 
Cultures (%) Cultures (%) 
Normal patients 17 2 (12,5 %) 3 (17,6%) 
Urological cancer 29 8 (27,6 %) 10(34%) 
Diabetes mellitus 7 4 (57 %) 5 (71 %) 
Chronic renal failure 3 1 (33 %) 1 (33 %) 
Table 4. Relationship of underlying systemic disease with rate of positive urine and 
double J stent cultures. 
4.1.3 Relationship of underlying systemic disease and sex with rate of positive urine 
and double J stent cultures 
Table 5 shows the correlation of patient underlying disease and sex with the rates 
of positive urine and stent tip culture. In each category of patients the rate of positive 
urine culture and stent colonisation was higher in females. The overall bacteriuria rate in 
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12 cases (50%) compared to that in men in 3 cases (9,3%) (p<0,001). The rate of 
bacteriuria in patients without systemic disease was significantly lower (12,5 %) than in 
patients with systemic disease (33 %) (p<0,001). Inside this group the rate of bacteriuria 
was 27,6 % in patients with cancer, 57 % with diabetes mellitus and 33 % with chronic 
renal failure. 
Group No.Pts. No.Pos. Urine Cultures 
(%) 
No.Pos. Stent Tip Cultures 
(%) 
man women man women 
Normal 17 0 2(11,7%) 0 3 (17,6%) 
Urological 
cancer 
29 2 (6,7 %) 6 (20,6 %) 2 (6,7 %) 8 (27,6 %) 
Diabetes 
mellitus 
7 1 (14 ,2%) 3 ( 4 2 , 8 % ) 1 (18,5%) 3 (42,8%) 
Chronic renal 
failure 
3 0 1 (33 %) 0 1 (33 %) 
Table 5. Relationship of underlying systemic disease and sex with rate of positive 
urine and double J stent cultures. 
• The frequency of positive urine cultures is significantly less in men than in 
women in the normal group p < 0,001. 
• The frequency of positive urine cultures is significantly less in men than in 
women in the urological cancer group p = 0,044. 
• No statistically significant difference in the frequency of positive urine cultures 
between men and women in diabetes (p = 0,14) 
No statistical analysis can be performed in the group of chronic renal failure because 
of the sample size. 
• The frequency of positive stent tip cultures is significantly less in men than in 
women in normal group (p<0,052). 
• The frequency of positive stent tip cultures is significantly less in men than in 
women in the urological cancer group p = 0,008 
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• No statistically significant difference in the frequency of positive stent tip cultures 
between men and women in diabetes (p = 0,14) 
No statistical analysis can be performed in the group of chronic renal failure because 
of the sample size. 
The colonisation rate was higher in women 66 % (16 cases) than in men 9,3% 
(3cases). Table 5 shows the microorganisms cultured from the urine of patients on the day 
of stent removal. The bacterial profile of the cultured samples from the tips of the stents 
was similar to that of the urine samples. The same organisms were isolated from urine and 
the stent tip in 11 cases (73,3%). The most frequent microorganism was E. coli in the 
urine and Enterococcus faecalis on the stent surface. 
Organisms No.Pts 
E. coli 7 
E. faecalis 4 
P. aeruginosa 2 
Klebsiella pneumoniae 1 
Streptococcus species 1 
Table 6. Microorganisms cultured from urine at stent removal. 
4.2 Heparin coating as one of preventive strategies concerning infections with 
urinary catheters 
The resistance of heparin coating to biofilm formation and encrustation in urinary 
catheters has been investigated only in recent times. We were also curious if heparin 
coating could be an advantage in patients with urinary devices. Therefore, we performed a 
number of in vitro and in vivo examinations, in which heparin coating and other materials 
of ureteral and urethral catheters were compared. 
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4.2.1 An in vitro examination of the ability of heparin-coated catheters to resist 
encrustation by crystalline P. mirabilis biofilm 
Whereas the hydrogel-coated latex catheter was blocked after an average of 28,1 
hours in 4 experiments, time until blockage was significantly longer for the heparin-
coated catheter (58,2 hours) and silicone catheter (54,8 hours) in the setting described 
(Figure 13). However, all 3 types of catheters were vulnerable to Proteus blockage. 
58,2 
1 54,8 
28,1 
0 20 40 60 80 
1 
Figure 13. The average blockage time of heparin-, silicone- and hydrogel-coated 
catheters 
The results of the in vitro examinations were as follows: 
• All 3 types of catheters were vulnerable to Proteus blockage. 
• There was no significant difference in time of blockage found in the 4 
experiments. 
• However, there was a close to significant difference between hydrogel-coated vs. 
heparin-coated catheters (p= 0,056). 
• Encrustation (REM) was observed only on hydrogel-coated and silicone catheters 
(especially around eyeholes and balloon). 
• No encrustation was found on heparin-coated catheters (blockage occurred by 
plugs of clear gel-like material). 
Encrustation (REM) was observed only on hydrogel-coated and silicone catheters 
especially around eyeholes and balloon but no encrustation was found on heparin-coated 
catheters; the blockage was caused by plugs of clear gel-like material (Figure 14 a,b). 
U heparin-coated 
catheter 
• silicone catheter 
I hydrogel-coated 
latex catheter 
hoi ir 
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a. b. 
Figure 14. (a) An uncoated ureteral stent with a biofilm formed on its inner surfaces. 
(b) A heaprin-coated ureteral stent which remains unaffected by biofilm 
formation and encrustation. 
4.2.2 Clinical evaluation of encrustation and biofilm formation on heparin-coated 
ureteral stents and nephrostomy tubes in a short period of time 
Electron microscopy showed a significant difference between heparin-coated and 
uncoated ureteral stents. Two weeks after the insertion, two types of deposits could be 
detected on the surfaces of the uncoated stents - amorph anorganic deposits consisting of 
mineralised crystals and the other of bacterial biofilms. Heparin-coated stents were 
unaffected by encrustations. After 6 weeks of indwelling time, all uncoated stents showed 
varying degrees and forms of deposits. (Figurel5). Within the limited observation period 
of this pilot study none of the uncoated stents became totally obstructed. The heparinised 
nephrostomy tubes remained unaffected for the whole 6 to 8 weeks indwelling periods 
(Figure 16), whereas uncoated tubes got obstructed within 2 to 3 weeks. 
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Figure 15. Developed encrustations and biofilms after 6 weeks of implantation on 
uncoated stents of different sections and enlargements. 
Figure 16. A cross section SEM picture of heparin-coated stent. No encrustation or 
biofllm detected on the stent surface after 6 weeks of implantation. 
This pilot study showed that no biofilms were detectable on heparin-coated stents, 
whereas significant biofilms were demonstrated in 33 % of uncoated stents. Mild 
encrustation was observed in 10 % of heparin stents compared to significant encrustation 
in 50 % of uncoated stents, and encrustations/biofilms were demonstrable on uncoated 
stents as early as 2 weeks after implantation (Figure 17). 
Figure 17. Encrustation, biofilm formation and colour change of heparin-coated 
ureteral stents and uncoated polyurethane stents (PUR) within a 6-week observation 
period (Y-axis is 0: no change, 1: moderate change and 2: significant change.) 
4.2.3 Clinical evaluation of encrustation and biofilm formation on heparin-coated 
ureteral stents and nephrostomy tubes during extended indwelling time 
No obstruction / blockage of the stents was observed during this time in Group 1. 
On REM none or only minimal encrustations were found after this prolonged indwelling 
time. In the difficult bacteria-exposed Group 2 situation, the silicone stents were found to 
be obstructed after 7 weeks while the hydrogel-coated stents in 5 months' time, whereas 
all of the heparin-coated stents were unaffected after 12 months of indwelling time 
(Figure 18). 
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Figure 18. Indwelling times for various ureteral stents in ileal conduits 
4.2.4 Comparison of the heparin-coated and polyurethane stents before the 
development of obstruction in the long time period of indwelling stents 
The average indwelling time of the polyurethane stents was 15 weeks (varied 4 to 
19). In the background of the removal of the stents was symptomatic urinary tract 
infection in 4 patients and signs of increasing obstruction were in 14 cases. We justified 
biofilm formation on the surface of the stents in 77,7 % of cases (14 patients) and we also 
isolated microorganisms in 66,6% of cases (in 12 patients) (Table 7). We detected 
encrustation in different grades in 94,4% on the inner and outer surfaces of the stents 
(17 patients). The average encrustation rate was the highest in the bladder followed by the 
ureteric and kidney portion of the stents. (Table 10). We found a significant difference 
between heparin-coated ureteral stents and polyurethane ones concerning biofilm 
formation and bacterial colonisation (Table 8, 9). 
In many cases the central channels of the stents and eye-holes were completely 
occluded (Figure 19). In contrast the average indwelling time of the heparin-coated stents 
was 11 months (varied 10 to 13 months). Obstruction or symptomatic UTI were not 
detected in any of the cases. We observed mild encrustation in 4 cases (30,7%, grade 1-2) 
and biofilm formation in 2 cases (15,3% of stents) (Figure 20). 
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Figure 19. The central channels of the stents and eye-holes are completely occluded. 
(a,b,c,) 
(d - enlargement) 
Figure 20. A heparin-coated stent with mild incrustation after 12 months' indwelling 
time (different sections, different enlargements). 
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Type of stents Total number 
examined 
Number (%) with 
visible biofilm 
Number (%) from which 
microbes were isolated 
PUR stent 18 77,7 (14) 66,6 (12) 
Heparin-coated 13 15,3 (2) 15,3 (2) 
Table 7. Biofilm formation and microbial colonisation of PUR and heparin-coated 
stents. 
Heparin-coated PU-stent All 
N % N % N % 
Without visible biofilm 11 84,6% 4 22,2% 15 48,4% 
With visible biofilm 2 15,4% 14 77,8% 16 51,6% 
13 100% 18 100% 31 100% 
chi-square test: p<0.005 
Fisher-test: p<0,005 
Table 8. Statistical analysis concerning biofilm formation between the two types of 
stents. The difference proved to be statistically significant. 
Heparin-coated PU-stent All 
Isolated microbes N % N % N % 
Microbes were not isolated 11 84,6% 6 33,3% 17 54,8% 
Microbes were isolated 2 15,4% 12 66,7% 14 45,2% 
13 100% 18 100% 31 100% 
chi-square test: p<0,005 
Fisher-test: p=0,01 
Table 9. The statistical analysis concerning microbial colonisation between the two 
types of stents. The difference proved to be statistically significant. 
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Stent type Mean encrustation scores on stent sections Mean total 
Bladder Ureteral Kidney encrustation scores 
PUR stent 3,1 2,7 2,4 2,7 
Heparin-coated 0,53 0,38 0,30 0,4 
Table 10. Summary of stent encrustation scores 
The mean values quoted were calculated from the data on 18 PUR stents and 13 
heparin-coated stents. The summary of the microbiological findings is given in table 11. 
Microbes were recovered from fewer of the heparin-coated stents than from the uncoated 
types (15,3% compared with 66,6%). 
Organisms Number of stents colonised by each organism (%) 
recovered Total PU-stent Heparin-coated 
Enterococcus spp. 5(16,1) 4 (22,2) 1(50) 
Escherichia coli 4(12,9) 3 (16,6) 1(50) 
Pseudomonas 2 (6,45) 2(11,1) 0(0) 
aeruginosa 
Coagulase -ve 2 (6,45) 2(11,1) 0(0) 
staphylococci 
Klebisella spp. 1 (3,2) 1 (5,5) 0(0) 
Table 11. Bacteria isolated from the stents 
4.3 The examination of antibiotic adsorption capability on ureteral stents 
During in vitro and in vivo examinations it was justified that fluoroquinolones are 
effective in a short- term period of time in prevention of biofilm formation on urinary 
catheters. It was also defined that ciprofloxacin and ofloxacin had a detectable level in 
conditioning film and on the surface of the stents. Data about the duration time of 
antibiotics on ureteral stents can be rarely found in literature. Thus, our task was to 
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evaluate the adsorption of levofloxacin - a 3rd generation fluoroquinolone on ureteral 
stents. We also searched for the answer to the question whether the intermittent or the 
continuous antibiotic treatment was more effective in patients wearing urinary catheters 
because of symptomatic urinary tract infections. 
4.3.1 Intermittent and continuous levofloxacin (Tavanic iv., tabl.500 mg) therapy 
results in drug adsorption on urinary devices and prevention of the urinary tract 
infections 
We didn't find any significant difference between the two groups of patients, 
neither concerning clinical, nor microbiological recovery. In the 1st group of patients the 
pain in the back caused by obstruction resolved in 37,5% of cases after 1-3 days of stent 
insertion. After 4-10 days 87,5% of patients, after 11-17 days all the patients were 
complaint free. We observed similar results in the second group of patients and we did not 
find any significant differences between the two groups. (Table 12) We did not record any 
significant discrepancies concerning urge, fever and the number of leukocytes between 
the two groups either. (Table 13,14) 
The patients of the continuous group were treated by 500mg of levofloxacin with 
the average time of 23 (20-25) days, but they took antibiotics during 20 days (19-22) until 
the stent removal (operation). On the other hand, patients of the intermittent group took 
levofloxacin for 7 days. 
During the HPLC examination we did not find any significant differences of the 
antibiotic adsorption level of the different parts of the stents ( kidney, ureter and bladder 
part)(Figure 21). 
Statistical analysis showed that significantly greater amount of levofloxacin adsorbed to 
the conditioning film than to the stent surface in both groups of patients (Table 15,16). 
We didn't find significant differences in the amount of levofloxacin which was observed 
in the conditioning film of the both groups (Table7). Similarily, there was no significant 
divergence in either group concerning the detectable antibiotic level on the stent surface 
(Table 18). The drug levels reached on all the device surfaces in both groups were higher 
than MIC of Escherichia coli (0,004-0,015 mg/1), the most common uropathogene. The 
drug levels in the film were higher than the MIC of other common pathogens, namely 
Pseudomonas aeruginosa (0,25-1 mg/1), Enterococcus faecalis (0,25-2 mg/1) and 
Staphylococcus aureus (0,12-0,5 mg/1) in 41,6% (10), 25% (6) and 66,6% (16) of cases. 
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No viable, adherent bacteria were recovered by sonication and culture in any of the 
patients, and no biofilms were seen under scanning electron microscopy in either of the 
groups. There were no significant differences in the early or late microbiological recovery 
rate in either group. Two weeks after the definitive curative treatment there was no 
bacteriuria in either group. On the other hand after 6 to 8 weeks we found it in one patient 
in each group. 
Figure 21. Representative chromatogram of a levofloxacin containing eiuent (HPLC 
water) obtained by desolving the conditioning film of the ureteral stent 
Continuous group Intermittent group 
Before stent insertion 8(100%) 15 (93,7%) a 
1 -3 days after stent insertion 5 (62,5%) 8 (50%)b 
4-10 days after stent insertion 1 (12,5%) 2 (12,5%)c 
11-17 days after stent 
insertion 
0% 1 (6,2%)d 
Tablel2. Development of back pain in the continuos and intermittent group 
achi-square test: p=0.47 Fisher-test: p=l comparison of the two groups 
b chi-square test: p=0.56 Fisher-test: p=0,68 comparison of the two groups 
c chi-square test: p=l Fisher-test: p=l comparison of the two groups 
d chi-square test: p=0,47 Fisher-test: p=l comparison of the two groups 
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Continuous group Intermittent group 
Before stent insertion 3 (37,5%) 3 (18,75%)a 
1-3 days after stent insertion 7 (87,5%) 12 (75%)b 
4-10 days after stent insertion 1 (12,5%) 2 (12,5%)° 
11-17 days after stent 
insertion 
4 (50%) 7 (43,7)d 
Table 13. Development of irritative symptoms in the continuous and intermittent 
group 
achi-square test: p=0.32 Fisher-test: p=0,36 comparison of the two groups 
b chi-square test: p=0.48 Fisher-test: p=0,63 comparison of the two groups 
c chi-square test: p=l Fisher-test: p=l comparison of the two groups 
d chi-square test: p=0,77 Fisher-test: p=l comparison of the two groups 
Continuous group Intermittent group 
The average number of 
leukocytes before stent 
insertion 
11,5 (6-14) 12,77 (6,9-26,7)a 
The average number of 
leukocytes at day of 
operation 
7,5 (4,4-10) 7,37(3-10)" 
Table 14. Development of the number of leukocytes in the continuous and 
intermittent groups. The average number of leukocytes before stent insertion 
between the two groups wasn't significant. 
at-test p=0,27, Wilcoxon-test p:0,54 
On the day of the operation there wasn't significant difference either. 
bt-test p=0,8 Wilcoxon-test p:0,87 
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Number of patients Mean treatment 
duration (day) 
Conditioning film 
(pg/ml) 
Stent surface 
(pg/ml) 
12 20 (19-22) 0,724 0,132a 
Table 15. Mean concentration of antibiotic (pg/ml) in the conditioning film of the 
stent and on stent surface in the patients who were continuously treated by 
levofloxacin (500mg/day). 
"paired t-test p=0,022 and Wilcoxon signed rank test, p=0,012 comparing 
levofloxacin concentration in conditioning film and concentration on the surface of 
the stent. The difference is statistically significant 
Number of patients Mean treatment 
duration (day) 
Conditioning film 
(pg/ml) 
Stent surface 
(pg/ml) 
12 7 0,237 0,098b 
Table 16. Mean concentration of antibiotic (pg/ml) in stent conditioning film and on 
stent surface in patients who stopped antibiotic therapy prior to stent removal. 
bpaired t-test p=0,061, and Wilcoxon signed rank test, p=0,02 comparing 
levofloxacin concentration in conditioning film and concentration on the surface of 
the stent. The difference is statistically significant 
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Conditioning 
film (pg/ml) 
N 
Mean 
(pg/ml) STD 
[95% 
Confidence Interval] Min Q25 Median Q75 Max 
Continuous 
group 
10 0.721 0.832 [0.19 ; 1.25] 0 0.102 0.419 1.327 2.497 
Intermittent 
group 
11 0.237 0.282 [0.07 ; 0.41] 0 0.025 0.081 0.553 0.723 
21 0.467 0.642 [0.19 ; 0.75] 0 0.07 0.186 0.59 2.497 
t-test: p=0.08 
Wilcoxon test: p =0.14 
Table 17. The level of levofloxacin concentration in the conditioning film in the two 
groups. There is no significant difference. 
Stent surface 
(pg/ml) 
N 
Mean 
(pg/ml) STD 
[95% 
Confidence Interval] Min Q25 Median Q75 Max 
Continuous 10 0.202 0.342 [-0.01 ; 0.42] 0 0.021 0.122 0.168 1.154 
group 
Intermittent 11 0.1 0.146 [0.01 ; 0.19] 0 0.011 0.047 0.126 0.504 
group 
21 0.148 0.257 [0.04 ; 0.26] 0 0.018 0.06 0.168 1.154 
t-test: p=0.38 
Wilcoxon test: p =0.34 
Table 18. The level of levofloxacin concentration on stent surfaces. There is no 
significant difference between the two groups. 
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5. DISCUSSION 
5.1. Factors predisposed to urinary tract infections during indwelling J ureteral 
catheterization 
Ureteral stents have an important role in the management of upper urinary tract 
obstruction and prevention of postoperative complications after endoscopic urological 
procedures. Their use is usually associated with mild morbidity, such as dysuria, urgency, 
suprapubic pain and urinary tract infections. The urinary tract remains the most common 
site of nosocomial infection. Urinary tract infection episodes are often resolved without 
treatment, but sometimes in the symptomatic patients treatment may be necessary. In the 
treatment of such patients the correct knowledge of the types of bacteria associated with 
these devices and their sensitivity is very important. 
Our study justfied that the risk of bacteriuria and colonisation of ureteral stents 
significantly depended on the duration of the insertion of stents and the underlying 
systemic diseases. The rate of bacteruria and J stent colonisation in patients with systemic 
disease was significantly higher than in those without such conditions. This finding may 
have been due to the fact that diabetes mellitus, urological cancer and chronic renal 
failure, which significantly decreased the immune system, encouraged the infection of 
urine and the stent tip. In almost all groups of patients the rate of J stent colonisation was 
higher than the rate of positive urine culture. 15 out of all the patients with positive urine 
culture at stent removal 5 (33%) had symptomatic urinary tract infection and 3 (20%) had 
septicaemia despite adequate antimicrobial treatment, causing premature stent removal. 
Since the patients were not on a therapeutic antibiotic regimen, this result is further proof 
that, as in patients with indwelling ureteral catheters, patients with J stents do not require 
empirical antibiotic therapy since only a small percentage had symptomatic urinary tract 
infection or septicaemia requiring stent removal and antibiotic treatment. All patients who 
had septicaemia were women who also had diabetes mellitus, indicating that patients with 
these systemic diseases should be closely followed for early detection and treatment of 
symptomatic urinary tract infection. 
Female gender is associated with higher rates of bacteruria and J stent 
colonisation than male gender. Furthermore, this association is higher in patients without 
systemic disease and in the presence of cancer in the urinary tract. 
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This study also shows that the most common pathogens isolated from urine at stent 
removal were Escherichia coli followed by Enterococcus feacalis and in 73,% of cases 
organisms cultured from the tips of the stents were similar. 
It is true that in the majority of our patients stent associated bacteriuria and stent 
colonisation were asymptomatic but it is prudent to recommend to give empirical 
antibiotic coverage to patients who are at high risk of infection. However, in normal 
patients the selection of resistant organisms and increased cost, argue against the routine 
use of empirical antimicrobial therapy for urinary tract infection in those with indwelling 
J stents at low risk of significant symptomatic bacteriuria or stent colonisation. Analysis 
of our details show that patients at high risk of infectious complications can be identified 
by careful follow up to reduce the morbidity associated with the device. 
5.2 Heparin coating as preventive strategy for the control of catheter-associated 
urinary tract infections 
Infection, encrustation and blockage of long-term indwelling catheters, ureteral 
stents and nephrostomy tubes are significant medical and health-economic problems. 
Because of these problems, about 50% of patients with permanent urinary drainage 
devices present as emergency cases during their course of disease and produce costs of up 
to US $ 1,5 billion per year in Western Europe. [3 7] Thus, effective strategies for the 
prevention of catheter-associated infections are necessary to interrupt the process of 
biofilm formation and encrustation. The prevention of bacterial adherence to biomaterial 
surfaces is an extremely difficult task to achieve, since a high number of adhesion 
mechanisms via various molecules exist. They are aspecific receptors, proteins, 
glycoproteins and lipopolysaccharides, that may even vary between different species of 
bacteria. In addition, the direct adhesions of human blood proteins (albumin, fibrinogen, 
and fibrinonectin) to catheter surfaces coat the modified anti-adhesive structures such as 
heparin and that may again facilitate bacterial adhesion. The complexity of the adhesion 
mechanisms is the reason why none of the anti-adherence strategies investigated hitherto 
proved to be optimal. 
The present pilot study confirms the result of several in vitro investigations that 
postulated the inhibition of biomaterial encrustation by heparin coating. In a clinical 
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setting, we were able to show that heparin-coated ureteral stents stayed free of deposits 
over the indwelling time for up to 6 weeks, whereas organic biofilms or organic crystals 
were observed on uncoated polyurethane stents as soon as 2 weeks after insertion. 
Three different ways for surface heparinisation of medical devices have been 
described. Whereas physically adsorbed heparin is released quickly within hours after 
insertion and is effective only during this limited period of time (only useful for 
interventional devices), heparin incorporated into polymers may not be released to a 
sufficient degree to prevent adhesion of molecules and cells. Covalent heparin bonding 
seems to be the procedure of choice, if stability is guaranteed for a longer period of time. 
The reduction of thromogenicity and bacterial colonisation using covalent heparin 
bonding has been demonstrated in a clinical pilot study on venous catheters. The present 
study extends these findings to catheters in the urinary tract. As a continuation of this 
pilot study, the indwelling times of heparin-coated ureteral stents have been extended to 3, 
6, and 12 months, and bacteriological evaluation of stent biofilms is added to the protocol. 
Heparin-coated ureteral stents are more expensive than standard stents. However, 
with longer indwelling times and reduction of the number of stent exchange procedures, 
the total costs for heparin stents should be reduced compared to other stents. Heparin-
coated stents cost 4 times the price of uncoated stents, the ratio is 2,3 for nephrostomy 
tubes and 6,5 for urethral catheters. If a stent exchange procedure is calculated at 200 
Euros (a very conservative estimation), the costs per year for various stents and variable 
indwelling times are demonstrated in figure 22. 
Similar calculations have been made for nephrostomy tubes and urethral catheters 
and show an advantage of the heparin-coated devices. Each institution has to check its 
own regime with regard to cost effectiveness, but the excellent qualities of the heparin-
coated urologic drainage devices add a new possibility to the urologic armamentarium. 
Besides the possible cost reduction for permanent urinary drainage, significant reduction 
of patients morbidity due to less obstruction, less emergency visits and less invasive 
procedures is a compelling argument. 
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Costs in € / Stents for permanent ureteral drainage 
6 PUR/yr 
4 PUR/yr 
2 Heparius/yr 
1 Heparius/yr 
180 
120 200 
200 
1200 
A 
120 800 
S 
240 400 
V 
400 600 800 1000 1200 1400 
Figure 22. Costs per year for heparin-coated ureteral (Heparius) and uncoated 
polyurethane stents (PUR). 
Our results unanimously justify that heparin coated urinary stents can resist 
biofilm formation and encrustation not only within short periods of time (6 weeks) but for 
longer terms as well (3 to 12 months). Heparin coating provides another alternative 
treatment of obstruction for the patients who are compelled to wear stents continuously 
during longer periods of time, thus preventing the frequent unpleasant and often 
unsuccessful change of the stents. 
5.3 The place of intermittent antibiotic treatment in case of urinary tract obstruction 
after temporary insertion of a foreign body. 
Previous in vitro and in vivo studies have shown that certain antimicrobial drugs 
(trimetropin-sulfamethoxazole, ampicillin, cefazolin, cephalexin, cloxacillin, cefuroxime, 
gentamicin, tobramycin) are able to eradicate the planktonic uropathogens associated with 
microbial biofilms, but they are not able to eradicate the bacteria that are adherent and 
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form biofilm. [64-66] In vitro studies have shown that ciprofloxacin can penetrate well-
established biofilms on catheter surfaces. 
Our study is one of the firsts, which examined the adsorption of antibiotics in vivo 
on stent surfaces. Reid at al and Wollin at al determined the level of ofloxacin and 
ciprofloxacin on the conditioning film and on stent surfaces. According to their studies 
both antibiotics could be detected and were observed in a significantly higher 
concentration in the conditioning film layer than on stent surfaces. Between the 
adsorption of the two antibiotics there was no significant difference. [80,81] A limited 
number of patients justified that on finishing antibiotic treatment after 1-2 weeks some 
amount of antibiotics could be still detected. 
It is likely that ofloxacin remained in the conditioning film in a bigger amount after 1-2 
weeks of finishing antibiotic treatment due to lasting diffusion. However, the investigators 
did not plan the time of antibiotic interruption and did not determine if the intermittence 
of the antibiotics was disadvantageous for the patients. References about levofloxacin 
adsorption to the foreign body surfaces cannot be found in literature yet. According to our 
results levofloxacin can better adsorb to stent surfaces than ofloxacin and is almost the 
same as ciprofloxacin comparing to Reid és Wollin's investigation results. Our data 
prove the hypotheses that the continuous antibiotic treatment does not have any 
advantages in patients with indwelling ureteral stents compared to intermittent or the so 
called 'pulse therapy'. In case of acute symptomatic urinary tract infections caused by 
obstruction it is enough to continue antibiotic treatment till the resolution of the acute 
symptoms in case of temporary resolution of obstruction. A repeated antibiotic treatment 
is satisfactory on the day of the definitive resolution of the obstruction. It is essential to 
pay attention to the adsorption capability when choosing the appropriate antibiotics, like 
for instance fluoroquinolones. Our study results back up that 'pulse therapy' can be 
effective in certain cases, when a three-day antibiotic treatment followed by a 7-10 days 
of antibiotic free period of time is more advantageous than continuous treatment by 
antibiotics or a wait-and-see therapy. It is also possible that stents with different material 
and with modified surfaces, will be quite receptive to certain drugs, and therefore the 
optimal patient management might use certain material-drug combination. 
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6. CONCLUSIONS 
6.1 We were the first to investigate the predisposing factors of urinary tract infections 
in patients with indwelling ureteral stents in Hungary. Our results justified that the 
indwelling time of stents, female gender and systemic diseases that negatively 
influence the immune system appear to be the predisposing factors of urinary tract 
infections of patients with indwelling ureteral stents. Our results suggest that in 
case of multipredisposing factors, such as female gender, advanced diabetes 
mellitus) in case of a short indwelling time of stents (< 1 month) empirical 
antibiotic coverage should be given. In the category of patients at high risk of 
urinary tract infection with a long-time indwelling ureteral stent, we recommend a 
careful follow up. We believe that with the administration of antimicrobial 
prophylaxis or a short-time antibiotic treatment at stent removal, the development 
of bacteremia or septicaemia can be minimized. However, in normal patients the 
selection of resistant organisms and the increased cost argue against the routine 
use of empirical antimicrobial therapy in those with indwelling J stents at low risk 
for significant symptomatic bacteriuria or stent colonisation. 
6.2 Together with Riedl and his Baden co-workers we were the first in Europe to 
investigate heparin-coated urinary catheters concerning biofilm formation and 
encrustation. Our in vitro and later in vivo studies showed that heparin coating can 
prevent biofilm formation and consecutive encrustation in short as well as in long 
periods of time. We compared the time of obstruction in patients with normal 
polyurethane and heparin-coated double J stents in the group of patients with 
similar conditions. We justified that heparin-coated ureteral stents can be safely 
maintained during a year's period of time with a considerable reduction of 
expenses. 
6.3 We were also among the first investigators to determine the antibiotic level of 
adsorption on ureteral stent surfaces. So far there hasn't been any data in literature 
about the adsorption capabilities of levofloxacin on ureteral stents or its preventive 
effect on biofilm formation. 
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6.4 For the first time in Hungary we compared the results of continuous and 
intermittent antibiotic treatment in patients who had complicated symptomatic 
urinary tract infection with inserted urinary devices. Our results confirmed that the 
continuous antibiotic treatment does not have any advantages compared to the 
intermittent treatment strategy. In contrast, the continuous treatment can increase 
the antimicrobial resistance to pathogens as well as the expenses of treatment. Our 
study proved that after two weeks of finishing antibiotic treatment levofloxacin 
levels reached on all the device surfaces were higher than the MIC of Escherichia 
coli. In our study we also compared the above mentioned results of levofloxacin 
treatment to study results with ciprofloxacin treatment. We came to the conclusion 
that levofloxacin can reach similar antibiotic level as ciprofloxacin on stent 
conditioning films. However, on the interruption of antibiotic treatment, the 
diffusion of levofloxacin from the conditioning film is much slower than of 
ciprofloxacin, and therefore it has longer effect in prevention of urinary tract 
infections. 
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